Anti-Amnesic and Neuroprotective Effects of Fluoroethylnormemantine in a Pharmacological Mouse Model of Alzheimer’s Disease

BACKGROUND: Current therapies in Alzheimer’s disease (AD), including Memantine, have proven to be only symptomatic but not curative or disease modifying. Fluoroethylnormemantine (FENM) is a structural analogue of Memantine, functionalized with a fluorine group that allowed its use as a positron emis...

Descripción completa

Detalles Bibliográficos
Autores principales: Couly, Simon, Denus, Morgane, Bouchet, Mélanie, Rubinstenn, Gilles, Maurice, Tangui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Regular Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883897/
https://www.ncbi.nlm.nih.gov/pubmed/32977336
http://dx.doi.org/10.1093/ijnp/pyaa075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883897/
https://www.ncbi.nlm.nih.gov/pubmed/32977336
http://dx.doi.org/10.1093/ijnp/pyaa075

Ejemplares similares